The FDA told CNBC this week the agency is conducting its review of Moderna’s vaccine for adolescents as quickly as possible.

Some countries have reported slightly higher rates of heart inflammation after Moderna’s vaccine than Pfizer’s, though the overall risk is low.

Covid-19 carries a much higher risk of myocarditis than vaccination, researchers have found.